Clinical Trials Directory

Trials / Unknown

UnknownNCT05211791

TEA, ESB and Paravertebral Block During Single-lung Ventilation for Lung Resection

Comparison Between Thoracic Epidural Anaesthesia, Erector Spinae Block and Paravertebral Block During Single-lung Ventilation for Lung Resection in Lateral Decubitus Position: A Prospective Randomized Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
South Egypt Cancer Institute · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Thoracotomy operations are known to be painful surgical procedures, so providing effective intraoperative and postoperative analgesia is so important for all anaesthesiologists. Ineffective pain management interferes with deep breathing, coughing, and remobilization resulting in atelectasis and pneumonia. Ultrasound-guided ESP block is a myofascial plane block that provides analgesia for thoracic or abdominal segmental innervation depending on the level of the injection site. Thoracic epidural analgesia (TEA) is considered the gold standard analgesic technique for thoracic surgeries. But the invasiveness of this technique, the rare but serious neurologic complications and the failure rates up to 30% are the disadvantages of epidural analgesia

Detailed description

The aim of this study is to compare the effect of different blocks as TEA, erector spinae block or paravertebral block on improving peri-operative analgesia and post-operative outcome in pulmonary resection in adult patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREerector spinae blockUltrasound-guided insertion of different analgesic procedures as paravertebral block anesthesia and paravertebral block anesthesia
PROCEDUREparavertebral block anesthesiaUltrasound-guided insertion of different analgesic procedures as paravertebral block anesthesia and paravertebral block anesthesia
PROCEDUREThoracic epidural anesthesiainsertion of Thoracic epidural catheter for anesthesia analgesia at level of T6

Timeline

Start date
2022-01-10
Primary completion
2023-06-10
Completion
2023-10-20
First posted
2022-01-27
Last updated
2023-05-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05211791. Inclusion in this directory is not an endorsement.